Mobix Labs, Inc. today filed a prospectus supplement under its existing Form S-3 registration (File No. 333-284351, declared effective January 24, 2025) indicating its intent to sell shares of common stock or equivalents in a registered public offering. D. Boral Capital is acting as sole placement agent. While final size and pricing remain subject to market conditions, the Company plans to use net proceeds for working capital and general corporate purposes, including R&D investment in its RF and mmWave product lines. The preliminary prospectus supplement will be available on the SEC’s website and by request from D. Boral Capital’s New York office, providing full disclosure of risks, use of proceeds, and forward-looking assumptions.

Mobix Labs has appointed industry veteran Amir Asvadi as General Manager of its EMI product line and defense manufacturing operations. Mr. Asvadi brings over 15 years of leadership at publicly traded defense firms, where he oversaw cross-functional teams in engineering, operations and sales. Concurrently, the Company plans to transition its West Coast operations into a larger military-approved facility expected to increase production capacity by 50% and consolidate manufacturing, quality control and assembly under one roof. This expansion supports current program integrations—such as EMI filters in the F-35 Lightning II, F/A-18 Super Hornet, F-22 Raptor, MH-47 Chinook and Apache Helicopter—and positions Mobix Labs to meet projected defense sector demand growth of 20% annually over the next three years.